Composition
- Active ingredients
- TREPROSTINIL 0.064MG/INH
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA214324.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Tyvaso Dpi
- Active substance
- treprostinil
- Route
- Inhalation
- Dosage form
- Powder
- Applicant
- United Therap
- Status
- Prescription
- FDA approval
- 23 May 2022
- Application
- NDA214324-004